Effect of Insurance Type on Adverse Cardiac Events After Percutaneous Coronary Intervention

被引:26
|
作者
Gaglia, Michael A., Jr. [1 ]
Torguson, Rebecca [1 ]
Xue, Zhenyi [1 ]
Gonzalez, Manuel A. [1 ]
Ben-Dor, Itsik [1 ]
Maluenda, Gabriel [1 ]
Mahmoudi, Michael [1 ]
Sardi, Gabriel [1 ]
Wakabayashi, Kohei [1 ]
Kaneshige, Kimberly [1 ]
Suddath, William O. [1 ]
Kent, Kenneth M. [1 ]
Satler, Lowell F. [1 ]
Pichard, Augusto D. [1 ]
Waksman, Ron [1 ]
机构
[1] Washington Hosp Ctr, Washington, DC 20010 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2011年 / 107卷 / 05期
关键词
ACUTE MYOCARDIAL-INFARCTION; SOCIOECONOMIC-STATUS; PAYER STATUS; HEALTH-CARE; ASSOCIATION; SERVICES; MORTALITY; SURVIVAL; INCOME; SIZE;
D O I
10.1016/j.amjcard.2010.10.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies have documented disparities in both access to invasive cardiovascular procedures and outcomes in patients with Medicaid, Medicare, or no insurance. Outcomes by insurance have yet not been examined in a percutaneous coronary intervention (PCI) population. Data from patients undergoing PCI from June 2000 to June 2009 were retrospectively analyzed. Insurance was categorized as private, Medicare, Medicaid, and uninsured, according to the primary insurance at discharge. The outcome variable of interest was major adverse cardiac events (a composite of death, Q-wave myocardial infarction, and target vessel revascularization) at 1 year. Multivariable Cox regression analysis was stratified according to age < 65 and >= 65 years. Of the 13,573 patients who had undergone PCI, 6,653 (49.0%) had private insurance, 6,150 (45.3%) had Medicare, 486 (3.6%) had Medicaid, and 284 (2.1%) were uninsured. Of the patients <65 years old, Medicaid (hazard ratio [HR] 1.59, 95% confidence interval [CI] 1.04 to 2.43), Medicare (HR 2.18, 95% CI 1.58 to 2.99), and no insurance (FIR 2.41, 95% CI 1.36 to 4.27) were associated with greater rates of adjusted major adverse cardiac events at 1 year compared with private insurance. Of the patients >= 65 years old, only Medicaid (HR 3.07, 95% CI 1.09 to 8.61) was associated with a greater rate of adjusted major adverse cardiac events at 1 year. In conclusion, patients with government-sponsored insurance and no insurance have worse cardiovascular outcomes than patients with private insurance after PCI at 1 year. This implies that the provision of health insurance alone might not have a dramatic effect on cardiovascular outcomes after PCI. (c) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;107:675-680)
引用
收藏
页码:675 / 680
页数:6
相关论文
共 50 条
  • [21] Machine learning models for prediction of adverse events after percutaneous coronary intervention
    Niimi, Nozomi
    Shiraishi, Yasuyuki
    Sawano, Mitsuaki
    Ikemura, Nobuhiro
    Inohara, Taku
    Ueda, Ikuko
    Fukuda, Keiichi
    Kohsaka, Shun
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [22] Machine learning models for prediction of adverse events after percutaneous coronary intervention
    Nozomi Niimi
    Yasuyuki Shiraishi
    Mitsuaki Sawano
    Nobuhiro Ikemura
    Taku Inohara
    Ikuko Ueda
    Keiichi Fukuda
    Shun Kohsaka
    [J]. Scientific Reports, 12
  • [23] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, S.
    Ishi, M.
    Otsuka, Y.
    Nakamura, T.
    Tsujita, K.
    Matoba, T.
    Kohro, T.
    Oba, Y.
    Kabutoya, T.
    Imai, Y.
    Kario, K.
    Kiyosue, A.
    Mizuno, Y.
    Nochioka, K.
    Nakayama, M.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [24] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, So
    Ishii, Masanobu
    Otsuka, Yasuhiro
    Nakamura, Taishi
    Tsujita, Kenichi
    Matoba, Tetsuya
    Kohro, Takahide
    Oba, Yusuke
    Kabutoya, Tomoyuki
    Imai, Yasushi
    Kario, Kazuomi
    Kiyosue, Arihiro
    Mizuno, Yoshiko
    Nochioka, Kotaro
    Nakayama, Masaharu
    Iwai, Takamasa
    Miyamoto, Yoshihiro
    Sato, Hisahiko
    Akashi, Naoyuki
    Fujita, Hideo
    Nagai, Ryozo
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 18
  • [25] Major adverse cardiac and cerebral events after percutaneous coronary intervention. A real world multicentre registry
    Livarek, B
    Lefevre, T
    Fosse, S
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 583 - 583
  • [26] Prognostic role of apolipoproteins on long-term major adverse cardiac events after percutaneous coronary intervention
    Kawahara, Hiroshi
    Endo, Akihiro
    Uchida, Kazuhiko
    Tanabe, Kazuaki
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 61 : 85 - 92
  • [27] Predicting major adverse cardiac events after percutaneous coronary intervention: The Texas Heart Institute risk score
    Madan, Pankaj
    Elayda, MacArthur A.
    Lee, Vei-Vei
    Wilson, James M.
    [J]. AMERICAN HEART JOURNAL, 2008, 155 (06) : 1068 - 1074
  • [28] Effect of enoxaparin on clinical events after percutaneous coronary intervention
    Tang, Nianzhong
    Chen, Shaoping
    Shi, Xiuying
    Ye, Zhong
    Zheng, Xing
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (07): : 10815 - 10824
  • [29] Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention
    Nozari, Younes
    Parsa, Maziar
    Jalali, Arash
    Ariannejad, Hamid
    Shafiee, Akbar
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (04) : 198 - 203
  • [30] Major Adverse Cardiac Events After Non-cardiac Surgery Following Previous Percutaneous Coronary Intervention With Stent Implantation
    Wasowicz, Marcin
    Syed, Summer
    Starzyk, Lukasz
    Wijeysundera, Duminda
    Beattie, Scott W.
    [J]. CIRCULATION, 2014, 130